Sensitivity analysis excluding patients with prior MI or ischemic stroke showed fewer MACE with GLP-1-RA exposure, but this did not reach statistical significance (weighted HR: 0.72 [0.49–1.05]; RD: -7.0 [-16.1 to 2.2]). The gene discussed is GLP1R; the disease is rheumatoid arthritis.